Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc.verified

VTYX

Price:

$2.55

Market Cap:

$179.77M

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of syst...[Read more]

Industry

Biotechnology

IPO Date

2021-10-21

Stock Exchange

NASDAQ

Ticker

VTYX

The PE Ratio as of July 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is -0.79

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.79. This represents a change of -85.30% compared to the average of -5.37 of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical PE Ratio (quarterly & annually)

How has VTYX PE Ratio performed in the past?

The mean historical PE Ratio of Ventyx Biosciences, Inc. over the last ten years is -60.57. The current -0.79 PE Ratio has changed 30.42% with respect to the historical average. Over the past ten years (40 quarters), VTYX's PE Ratio was at its highest in in the December 2023 quarter at -0.78. The PE Ratio was at its lowest in in the September 2021 quarter at -19.45.

Quarterly (TTM)
Annual

Average

-60.57

Median

-15.94

Minimum

-236.36

Maximum

-0.75

Ventyx Biosciences, Inc. (VTYX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 24.75%

Maximum Annual PE Ratio = -0.75

Minimum Annual Increase = -95.30%

Minimum Annual PE Ratio = -236.36

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.75-95.30%
2022-15.9424.75%
2021-12.77-65.52%
2020-37.05-84.32%

Ventyx Biosciences, Inc. (VTYX) Average PE Ratio

How has VTYX PE Ratio performed in the past?

The current PE Ratio of Ventyx Biosciences, Inc. (VTYX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-9.82

5-year avg

-60.57

10-year avg

-60.57

Ventyx Biosciences, Inc. (VTYX) PE Ratio vs. Peers

How is VTYX’s PE Ratio compared to its peers?

Ventyx Biosciences, Inc.’s PE Ratio is greater than Arcellx, Inc. (-65.30), greater than Immunocore Holdings plc (-24.38), greater than Vaxcyte, Inc. (-20.87), greater than DICE Therapeutics, Inc. (-23.17), greater than Nuvalent, Inc. (-34.81), greater than Cerevel Therapeutics Holdings, Inc. (-16.92), greater than Travere Therapeutics, Inc. (-4.69), greater than Structure Therapeutics Inc. (-17.82), less than Replimune Group, Inc. (0), greater than Ascendis Pharma A/S (-2.81), greater than United Therapeutics Corporation (-14.09), less than IDEAYA Biosciences, Inc. (14.73), greater than Protagonist Therapeutics, Inc. (-23.83), less than Verona Pharma plc (13.35), greater than Syndax Pharmaceuticals, Inc. (-29.16), greater than null (-8.17),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ventyx Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ventyx Biosciences, Inc. (VTYX)?

What is the highest PE Ratio for Ventyx Biosciences, Inc. (VTYX)?

What is the 3-year average PE Ratio for Ventyx Biosciences, Inc. (VTYX)?

What is the 5-year average PE Ratio for Ventyx Biosciences, Inc. (VTYX)?

How does the current PE Ratio for Ventyx Biosciences, Inc. (VTYX) compare to its historical average?